Immutep Limited - ADR
NASDAQ:IMMP
Immutep Limited - ADR Stock, NASDAQ:IMMP
95 Pitt Street, Level 12, Sydney, New South Wales (NSW) 2000
Australia
Phone: +61.2.8315.7003
Number of Employees:
Description
Immutep Ltd. is a biotechnology company, which engages in the research and development of immunotherapeutic treatments for cancer and autoimmune diseases. Its product is IMP321, which involves in clinical development for the treatment of breast cancer and melanoma. The company was founded on May 21, 1987 and is headquartered in Sydney, Australia.